FHTX - Foghorn Therapeutics Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Foghorn Therapeutics Inc.
IPO Date: October 23, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $124.12M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 4.20%
Avg Daily Range (30 D): $0.15 | 3.68%
Avg Daily Range (90 D): $0.17 | 3.58%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .89M
Avg Daily Volume (90 D): .45M
Trade Size
Avg Trade Size (Sh.): 89
Avg Trade Size (Sh.) (30 D): 162
Avg Trade Size (Sh.) (90 D): 110
Institutional Trades
Total Institutional Trades: 98
Avg Institutional Trade: $1.48M
Avg Institutional Trade (30 D): $1.13M
Avg Institutional Trade (90 D): $1.24M
Avg Institutional Trade Volume: .17M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.5M
Avg Closing Trade (30 D): $.59M
Avg Closing Trade (90 D): $1.83M
Avg Closing Volume: 232.32K
 
News
Jul 1, 2026 @ 11:00 AM
Step Pharma announces the appointment of Neil Gall...
Source: Step Pharma
Apr 9, 2026 @ 11:00 AM
Foghorn Therapeutics to Present New Preclinical Da...
Source: Na
Jan 14, 2026 @ 3:52 PM
Precision Killers: Why Big Pharma is Betting Billi...
Source: Prnewswire
Jan 10, 2026 @ 3:20 AM
Foghorn Therapeutics Highlights January Equity Fin...
Source: Na
Nov 17, 2025 @ 11:00 AM
4DMT Appoints Kristian Humer as Chief Financial Of...
Source: 4D Molecular Therapeutics
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.98 $-.1 $-.29
Diluted EPS $-.98 $-.1 $-.29
Revenue $36.74M $16.07M $3.27M
Gross Profit
Net Income / Loss $-64.58M $-7.19M $-19.88M
Operating Income / Loss $-72.76M $-8.81M $-21.57M
Cost of Revenue
Net Cash Flow $-5.74M $-20.83M $6.79M
PE Ratio